論文

査読有り 国際誌
2019年4月

A 12-year Recurrence-free Survival After Multidisciplinary Treatment for a Patient With Combined Hepatocellular-Cholangiocarcinoma.

Anticancer research
  • Tatsunori Miyata
  • ,
  • Toru Beppu
  • ,
  • Y U Imamura
  • ,
  • Hiromitsu Hayashi
  • ,
  • Katsunori Imai
  • ,
  • Akira Chikamoto
  • ,
  • Yo-Ichi Yamashita
  • ,
  • Kotaro Fukubayashi
  • ,
  • Takatoshi Ishiko
  • ,
  • Hideo Baba

39
4
開始ページ
2139
終了ページ
2144
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.21873/anticanres.13327
出版者・発行元
INT INST ANTICANCER RESEARCH

We report a 64-year-old woman with a 9-cm liver tumor in the left lateral section. The patient had neither hepatitis B or C virus infection, nor cirrhosis. Carbohydrate antigen 19-9 (CA 19-9) level was 1,889 U/ml. We also suspected bulky hilar lymph node metastasis, and a left lateral sectionectomy without lymph node dissection (R2) was performed. The pathological findings led to diagnosis of combined hepatocellular and cholangiocarcinoma. Three weeks post-operation, the patient underwent hepatic arterial infusion chemotherapy with cisplatin, fluorouracil, and mitomycin C. In addition, a total dose of 45 Gy of irradiation for the hilar lymph node was performed; while oral tegafur-uracil (UFT) has been administered for 10 years at a dose of 400 mg/day. The CA19-9 level of the patient was normalized after hepatectomy, hepatic arterial infusion, irradiation for hilar lymph node, and oral UFT administration. Currently, the patient is alive without any relapse for 12 years post-operation.

リンク情報
DOI
https://doi.org/10.21873/anticanres.13327
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/30952760
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000463619600059&DestApp=WOS_CPL
ID情報
  • DOI : 10.21873/anticanres.13327
  • ISSN : 0250-7005
  • eISSN : 1791-7530
  • PubMed ID : 30952760
  • Web of Science ID : WOS:000463619600059

エクスポート
BibTeX RIS